These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1765018)

  • 1. Monitoring impact of oral poliovirus vaccine on poliomyelitis trends from physiotherapy records, Ilorin, Nigeria, 1981-1988.
    Babaniyi OA; Yeya-Agba B; Parakoyi DB
    East Afr Med J; 1991 Aug; 68(8):642-8. PubMed ID: 1765018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of physiotherapy records to monitor the efficacy of a poliomyelitis vaccination programme in Ilorin, Nigeria 1981-1988.
    Babaniyi OA; Yeye-Agba B; Parakoyi DB
    Trop Doct; 1991 Apr; 21(2):69-72. PubMed ID: 1871883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
    Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
    Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016.
    Shirreff G; Wadood MZ; Vaz RG; Sutter RW; Grassly NC
    Emerg Infect Dis; 2017 Feb; 23(2):258-263. PubMed ID: 27861118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).
    Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ;
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward poliomyelitis eradication - Nigeria, January 2009-June 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(26):802-7. PubMed ID: 20613703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward poliomyelitis eradication--Africa, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(15):321-5. PubMed ID: 9132585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE; Abed Y; Marcus O; Gerichter CB; Melnick JL
    Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward interruption of wild poliovirus transmission--worldwide, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):308-12. PubMed ID: 19343011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1150-4. PubMed ID: 19847150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.